The east and west coasts of the US are hotbeds of scientific and medical innovation. We’ve been developing relationships, establishing partnerships, and finding new ways to collaborate with leaders in these regions for a while. Now our strategy of developing new medicines through collaboration with academic scientists, biotechnology companies and investment partners is headed to the next level—GSK is opening two small R&D satellite offices, based in San Diego and Boston.
Each office will help manage current external relationships and collaborations as well as identify and review new opportunities. The San Diego office will focus on the entire US west coast corridor from San Diego-Los Angeles-San Francisco-Seattle. The Boston satellite will be located in Kendal Square, Boston/Cambridge, and will comprise key business development and scientific staff to source and attract early innovation.
This approach represents the opportunity to establish a unique model—mixing the best GSK ‘know-how’ with local academic excellence and entrepreneurship—creating “a customized way to access innovation in the densest biomedical research communities in the world,” said Lon Cardon, SVP, Alternative Discovery and Development.
Our goal is to access innovation where it’s happening. Becoming more a part of the local east and west coast ecosystems of VCs, biotechs, and academics, we think will make us a partner of choice. Have an idea? Give us a shout!